Title |
Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions
|
---|---|
Published in |
Current Gastroenterology Reports, July 2013
|
DOI | 10.1007/s11894-013-0337-1 |
Pubmed ID | |
Authors |
Thomas J. Borody, Sudarshan Paramsothy, Gaurav Agrawal |
Abstract |
Fecal microbiota transplantation (FMT) has attracted great interest in recent years, largely due to the global Clostridium difficile infection (CDI) epidemic and major advances in metagenomic sequencing of the gastrointestinal (GI) microbiota, with growing understanding of its structure and function. FMT is now recommended as the most effective therapy for relapsing CDI and, with further refinement, may even be used in "first-time" CDI. There is interest also in other conditions related to GI dysbiosis--for example, inflammatory bowel disease, irritable bowel syndrome, obesity, and diabetes mellitus--although quality evidence is at present lacking. A few trials are now underway in FMT for ulcerative colitis. Many unanswered questions remain, including FMT methodology--for example, optimal route of administration, what makes a "good donor," safety issues, and long-term effects of FMT. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 18% |
Canada | 1 | 9% |
United States | 1 | 9% |
Unknown | 7 | 64% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 64% |
Practitioners (doctors, other healthcare professionals) | 4 | 36% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | <1% |
Germany | 1 | <1% |
Chile | 1 | <1% |
France | 1 | <1% |
Panama | 1 | <1% |
Israel | 1 | <1% |
United Kingdom | 1 | <1% |
Japan | 1 | <1% |
United States | 1 | <1% |
Other | 0 | 0% |
Unknown | 427 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 79 | 18% |
Student > Ph. D. Student | 67 | 15% |
Student > Master | 58 | 13% |
Researcher | 51 | 12% |
Student > Doctoral Student | 28 | 6% |
Other | 86 | 20% |
Unknown | 67 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 127 | 29% |
Agricultural and Biological Sciences | 75 | 17% |
Biochemistry, Genetics and Molecular Biology | 46 | 11% |
Immunology and Microbiology | 30 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 16 | 4% |
Other | 56 | 13% |
Unknown | 86 | 20% |